Your browser doesn't support javascript.
loading
Dutch, UK and US professionals' perceptions of screening for Barrett's esophagus and esophageal adenocarcinoma: a concept mapping study.
Sijben, Jasmijn; Rainey, Linda; Peters, Yonne; Fitzgerald, Rebecca C; Wani, Sachin; Kolb, Jennifer M; Broeders, Mireille J M; Siersema, Peter D.
  • Sijben J; Department of Gastroenterology and Hepatology (Route 455), Radboud University Medical Center, Geert Grooteplein-Zuid 8, 6500 HB, Nijmegen, the Netherlands. jasmijn.sijben@radboudumc.nl.
  • Rainey L; Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Peters Y; Department of Gastroenterology and Hepatology (Route 455), Radboud University Medical Center, Geert Grooteplein-Zuid 8, 6500 HB, Nijmegen, the Netherlands.
  • Fitzgerald RC; Early Cancer Institute, University of Cambridge, Cambridge, UK.
  • Wani S; Division of Gastroenterology and Hepatology, University of Colorado Anschutz Medical Center, Aurora, USA.
  • Kolb JM; Division of Gastroenterology, Hepatology and Parenteral Nutrition, VA Greater Los Angeles Healthcare System, David Geffen School of Medicine at UCLA, Los Angeles, USA.
  • Broeders MJM; Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Siersema PD; Dutch Expert Centre for Screening, Nijmegen, The Netherlands.
BMC Cancer ; 23(1): 1111, 2023 Nov 14.
Article en En | MEDLINE | ID: mdl-37964213
ABSTRACT

BACKGROUND:

Novel, less-invasive technologies to screen for Barrett's esophagus (BE) may enable a paradigm shift in early detection strategies for esophageal adenocarcinoma (EAC). Understanding professionals' perspectives on screening is important to determine how to proceed. We aimed to explore and compare professionals' perceptions of screening for BE and EAC screening in three countries.

METHODS:

In this study, 29 Dutch, 20 British and 18 American health care professionals (clinicians, researchers and policy makers) participated in concept mapping a mixed-methods consensus building methodology. Statements on perceived barriers, facilitators, advantages, disadvantages, implications or worries associated with screening for BE and EAC were collected in asynchronous digital brainstorm sessions. Subsequently, participants sorted the statements into groups according to thematic similarity and assessed the relevance of each statement in evaluating the acceptability of BE and EAC screening. Multidimensional scaling and cluster analysis were used to map the associations between generated statements.

RESULTS:

Professionals across three countries identified eight consistent themes that relate to their perceptions of screening for BE and EAC (1) Benefits, (2) Harms, (3) Clinical effectiveness concerns, (4) Screening population, (5) Screening modality, (6) Resources, (7) Ownership, and (8) Public communication. Dutch and American professionals prioritized the potential health benefits of screening but also questioned clinical impact. In contrast, British participants prioritized identification of the screening population and suitable test.

CONCLUSIONS:

Most professionals see potential in less-invasive screening tests for BE and EAC but underline the need to define the target screening population and determine benefits and harms before widely employing them. Successful implementation will require thoughtful consideration of the involvement of general practitioners, readiness of endoscopy and pathology services, balanced public communication, and country-specific regulations.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Esófago de Barrett / Neoplasias Esofágicas / Adenocarcinoma Límite: Humans País como asunto: Europa Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Esófago de Barrett / Neoplasias Esofágicas / Adenocarcinoma Límite: Humans País como asunto: Europa Idioma: En Año: 2023 Tipo del documento: Article